Author:
Franco Valentina,Canevini Maria Paola,Capovilla Giuseppe,De Sarro Giovambattista,Galimberti Carlo Andrea,Gatti Giuliana,Guerrini Renzo,La Neve Angela,Rosati Eleonora,Specchio Luigi Maria,Striano Salvatore,Tinuper Paolo,Perucca Emilio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference23 articles.
1. Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol. 2012;11(7):579–88.
2. Perucca E. Designing clinical trials to assess antiepileptic drugs as monotherapy: difficulties and solutions. CNS Drugs. 2008;22(11):917–38.
3. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs. I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62(8):1252–60.
4. National Institute for Health and Care Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE Clinical Guideline 137. http://guidance.nice.org.uk/CG137/NICEGuidance/pdf . Accessed 20 March 2014.
5. Larkin M. Warner–Lambert found guilty of promoting neurontin off label. Lancet Neurol. 2004;3(7):387.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献